BTMD · biote Corp.
$1.63
-0.63 (-27.88%)
At close · Aug 6
Market Cap
$61.26M
Shares
37.58M
biote Corp. Earnings Call Transcripts
Every quarterly earnings call for biote Corp. (BTMD) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲18%
$41.97M
$15,000
'22 Q3
22-11-08
·
$44.48M
$447,518
'22 Q4
23-03-28
▲20.7%
$44.84M
−$6.80M
'23 Q1
23-05-09
▲19.1%
$49.26M
−$5.14M
'23 Q2
23-08-10
▲8.5%
$45.56M
$7.53M
'23 Q3
23-11-07
▲2.7%
$45.70M
$7.73M
'23 Q4
24-03-12
▲4.4%
$46.80M
−$4.16M
'24 Q1
24-05-07
▼0.2%
$49.17M
−$7.09M
'24 Q2
24-08-08
▲12.8%
$51.38M
$10.70M
'24 Q3
24-11-12
▲9%
$49.83M
$3.70M
'24 Q4
25-03-12
▲4.7%
$48.99M
$13.72M
'25 Q1
25-05-07
▼0.6%
$48.86M
$3.19M
'25 Q2
25-08-06
▼6.7%
$47.96M
$8.19M
'25 Q3
25-11-05
▼6.9%
$46.41M
$1.95M
'25 Q4
26-03-11
LATEST
▼8.3%
$44.94M
$2.28M
'26 Q1
26-05-06
Earnings call
FY26 · Q2
2026-08-05
biote Corp. Q2 FY2026 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-06
biote Corp. Q1 FY2026 Earnings Call
Cautious tone
Voluntary product recall
Asteria Health production recovery
Revenue and procedure volume
Revenue
$44.94M
▼ 8.3% YoY Diluted EPS
$0.06
▼ 83.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-11
biote Corp. Q4 FY2025 Earnings Call
Positive tone
Procedure revenue decline
Voluntary product recall
New clinic and practitioner growth
Revenue
$46.41M*
▼ 6.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-05
biote Corp. Q3 FY2025 Earnings Call
Balanced tone
Commercial team rebuild
Practitioner network and marketing event
Procedure revenue decline
Revenue
$47.96M
▼ 6.7% YoY Diluted EPS
$0.22
▼ 33.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-06
biote Corp. Q2 FY2025 Earnings Call
Cautious tone
Procedure revenue softness and restructuring
New clinic additions and attrition
Adjusted EBITDA and profitability
Revenue
$48.86M
▼ 0.6% YoY Diluted EPS
$0.10
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
biote Corp. Q1 FY2025 Earnings Call
Positive tone
Procedure Revenue Decline and Recovery
Commercial Restructuring and Reorganization
Gross Margin Expansion from 503B Vertical Integration
Revenue
$48.99M
▲ 4.7% YoY Diluted EPS
$0.37
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-12
biote Corp. Q4 FY2024 Earnings Call
Positive tone
Clinical decision support software (CDSS) transition
Practitioner network expansion
2025 financial outlook
Revenue
$49.83M*
▲ 9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-12
biote Corp. Q3 FY2024 Earnings Call
Positive tone
Procedures and Clinical Decision Support software
2025 outlook and growth drivers
Vertical integration / Asteria Health manufacturing
Revenue
$51.38M
▲ 12.8% YoY Diluted EPS
$0.33
▲ 37.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
biote Corp. Q2 FY2024 Earnings Call
Positive tone
Gross margin and profitability outlook
BioteRx platform enhancements and rollout
Asteria Health integration and licensing
Revenue
$49.17M
▼ 0.2% YoY Diluted EPS
$-0.21
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
biote Corp. Q1 FY2024 Earnings Call
Positive tone
BioteRx product launch
Procedure revenue growth
Practitioner training and onboarding
Revenue
$46.80M
▲ 4.4% YoY Diluted EPS
$-0.12
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-12
biote Corp. Q4 FY2023 Earnings Call
Positive tone
2024 outlook and guidance
BioteRx wellness launch
Sales force optimization and practitioner network
Revenue
$45.70M*
▲ 2.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-07
biote Corp. Q3 FY2023 Earnings Call
Revenue
$45.56M
▲ 8.5% YoY Diluted EPS
$0.24
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-10
biote Corp. Q2 FY2023 Earnings Call
Revenue
$49.26M
▲ 19.1% YoY Diluted EPS
$-0.25
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
biote Corp. Q1 FY2023 Earnings Call
Revenue
$44.84M
▲ 20.7% YoY Diluted EPS
$-0.39
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-28
biote Corp. Q4 FY2022 Earnings Call
Revenue
$44.48M*
Rev · 5q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-08
biote Corp. Q3 FY2022 Earnings Call
Revenue
$41.97M
▲ 18% YoY Diluted EPS
$0.00
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-10
biote Corp. Q2 FY2022 Earnings Call
Revenue
$41.36M
▲ 19% YoY Diluted EPS
$-0.34
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Showing 1–17 of 17 earnings calls